Prostate-Specific Membrane Antigen PET/CT Suitable Imaging for Prostate Cancer
Prostate-specific membrane antigen PET/CT was found to be a suitable replacement for conventional imaging in patients with prostate cancer, providing superior accuracy to the combined findings of CT and bone scanning. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Polypharmacy in Patients with Cancer Over 65 May Predict Hospitalization
In this study, polypharmacy during the 6-month time period pre-IV chemotherapy was highly predictive of post-chemotherapy inpatient hospitalization. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia
The FDA has approved a phase III clinical trial to assess the safety and efficacy of intravenous tocilizumab (Actemra) plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
ESMO Addresses COVID-19 and Cancer Care
The European Society for Medical Oncology released key answers to questions about the coronavirus disease 2019 (COVID-19) as it pertains to cancer care. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Phase II Study of Pembrolizumab in Advanced Rare Cancers Shows Promise
Favorable toxicity profiles and antitumor activity seen in this phase II study of pembrolizumab supports further evaluation of the drug in this patient population. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
